Protecting pancreatic β-cells

IUBMB Life

Volumn 56, Issue 7, 2004, Pages 387-394

  Pileggi, Antonello ^a   Fenjves, Elizabeth S ^a   Klein, Dagmar ^a   Ricordi, Camillo ^a   Pastori, Ricardo L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Beta cell; Cell death; Cytoprotection; Gene therapy; Islet transplantation; Protein transduction domains; Type 1 diabetes

Indexed keywords

CALCITRIOL; CARBON MONOXIDE; CYCLOOXYGENASE 2 INHIBITOR; DEXTRAN; ENDOTOXIN; ESTRADIOL; GLUCAGON LIKE PEPTIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISOFYLLINE; MELAGATRAN; NICOTINAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PROTEINASE INHIBITOR; PROTOPORPHYRIN; PYRUVIC ACID; SCATTER FACTOR; SOMATOMEDIN; SUPEROXIDE DISMUTASE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APOPTOSIS; AUTOIMMUNE DISEASE; BINDING SITE; CELL DEATH; CELL PROTECTION; CHEMICAL ANALYSIS; CONTROLLED STUDY; GENE THERAPY; GENE VECTOR; GENETIC ANALYSIS; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; ISOLATION PROCEDURE; MOLECULAR BIOLOGY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; REVIEW; TREATMENT OUTCOME;

CYTOPROTECTION; DIABETES MELLITUS, TYPE 1; GENE THERAPY; GENETIC VECTORS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; PROTEIN TRANSPORT;

EID: 9444265904     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540400006469     Document Type: Review

References (70)

1. Kaufman, F. R. (2003) Type 1 diabetes mellitus. Pediatr. Rev. 24, 291-300.
2. Soltesz, G. (2003) Diabetes in the young: a paediatric and epidemiological perspective. Diabetologia 46, 447-454.
3. Santiago, J. V. (1993) Lessons from the Diabetes Control and Complications Trial. Diabetes 42, 1549-1554.
4. Stock, P. G., and Bluestone, J. A. (2004) Beta-cell replacement for type I diabetes. Annu. Rev. Med. 55, 133-156.
5. Ricordi, C., and Strom, T. B. (2004) Clinical islet transplantation: advances and immunological challenges. Nat. Rev. Immunol. 4, 259-268.
6. Kaufman, D. B., and Lowe, W. L., Jr. (2003) Clinical islet transplantation. Curr. Diab. Rep. 3. 344-350.
7. Hirshberg, B., Rother, K. I., Digon III, B. J., Venstrom, J., and Harlan, D. M. (2003) State of the art: islet transplantation for the cure of type 1 diabetes mellitus. Rev. Endocr. Metab. Disord. 4, 381-389.
8. Seung, E., Mordes, J. P., Greiner, D. L., and Rossini, A. A. (2003) Induction of tolerance for islet transplantation for type 1 diabetes. Curr. Diab. Rep. 3, 329-335.
9. Ballinger, W. F., and Lacy, P. E. (1972) Transplantation of intact pancreatic islets in rats. Surgery 72, 175-186.
10. Ricordi, C., Lacy, P. E., Finke, E. H., Olack, B. J., and Scharp, D. W. (1988) Automated method for isolation of human pancreatic islets. Diabetes 37, 413-420.
11. Shapiro, A. M., Lakey, J. R., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M., and Rajotte, R. V. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen [see comments]. N. Engl. J. Med. 343, 230-238.
12. Pileggi, A., Ricordi, C., Alessiani, M., and Inverardi, L. (2001) Factors influencing Islet of Langerhans graft function and monitoring. Clin. Chim. Acta 310, 3-16.
13. Fiedor, O., Goodman, E. R., Sung, R. S., Shimomura, K., Kwiatkowski, P. A., and Hardy, M. A. (1996) Factors that can affect cadaveric islet graft function include hemodynamic changes in the donor prior to organ harvest. Transplant. Proc. 28, 169-170.
14. Brunicardi, F. C., Dyen, Y., Brostrom, L., Kleinman, R., Colonna, J., Gelabert, H., and Gingerich, R. (2000) The circulating hormonal milieu of the endocrine pancreas in healthy individuals, organ donors, and the isolated perfused human pancreas. Pancreas 21, 203-211.
15. Contreras, J. L., Eckstein, C., Smyth, C. A., Sellers, M. T., Vilatoba, M., Bilbao, G., Rahemtulla, F. G., Young, C. J., Thompson, J. A., Chaudry, I. H., et al. (2003) Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes 52, 2935-2942.
16. Wang, R. N., and Rosenberg, L. (1999) Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship. J. Endocrinol. 163, 181-190.
17. Berney, T., Molano, R. D., Cattan, P., Pileggi, A., Vizzardelli, C., Oliver, R., Ricordi, C., and Inverardi, L. (2001) Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 71, 125-132.
18. Vives-Pi, M., Somoza, N., Fernandez-Alvarez, J., Vargas, F., Caro, P., Alba, A., Gomis, R., Labeta, M. O., and Pujol-Borrell, R. (2003) Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin. Exp. Immunol. 133, 208-218.
19. Eizirik, D. L., and Mandrup-Poulsen, T. (2001) A choice of death-the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44, 2115-2133.
20. Lenzen, S., Drinkgern, J., and Tiedge, M. (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol Med. 20, 463-466.
21. Johansson, U., Olsson, A., Gabrielsson, S., Nilsson, B., and Korsgren, O. (2003) Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation, Biochem. Biophys. Res. Commun. 308, 474-479.
22. Piemonti, L., Leone, B. E., Nano, R., Saccani, A., Monti, P., Maffi, P., Bianchi, G., Sica, A., Peri, G., Melzi, R., et al. (2002) Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 51, 55-65.
23. Moberg, L., Johansson, H., Lukinius, A., Berne, C., Foss, A., Kallen, R., Ostraat, O., Salmela, K., Tibell, A., Tufveson, G., et al. (2002) Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 360, 2039-2045.
24. Bennet, W., Sundberg, B., Groth, C. G., Brendel, M. D., Brandhorst, D., Brandhorst, H., Bretzel, R. G., Elgue, G., Larsson, R., Nilsson, B., et al. (1999) Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 48, 1907-1914.
25. Rafael, E., Ryan, E. A., Paty, B. W., Oberholzer, J., Imes, S., Senior, P., McDonald, C., Lakey, J. R., and Shapiro, A. M. (2003) Changes in liver enzymes after clinical islet transplantation. Transplantation 76. 1280-1284.
26. Brissova, M., Fowler, M., Wiebe, P., Shostak, A., Shiota, M., Radhika, A., Lin, P. C., Gannon, M., and Powers, A. C. (2004) Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes 53, 1318-1325.
27. Kuroda, Y., Kawamura, T., Suzuki, Y., Fujiwara, H., Yamamoto, K., and Saitoh, Y. (1988) A new, simple method for cold storage of the pancreas using perfluorochemical, Transplantation 46, 457-460.
28. Giannoukakis, N., and Trucco, M. (2003) Gene therapy technology applied to disorders of glucose metabolism: promise, achievements, and prospects. Biotechniques 35, 122-145.
29. Bottino, R., Lemarchand, P., Trucco, M., and Giannoukakis, N. (2003) Gene- and cell-based therapeutics for type I diabetes mellitus. Gene Ther. 10, 875-889.
30. Rabinovitch, A., Suarez-Pinzon, W., Strynadka, K., Ju, Q., Edelstein, D., Brownlee, M., Korbutt, G. S., and Rajotte, R. V. (1999) Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 48, 1223-1229.
31. Contreras, J. L., Bilbao, G., Smyth, C., Eckhoff, D. E., Xiang, X. L., Jenkins, S., Cartner, S., Curiel, D. T., Thomas, F. T., and Thomas, J. M. (2001) Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complement. Surgery 130, 166-174.
32. Darville, M. I. and Eizirik, D. L. (2001) Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-kappaB and C/EBP. Diabetes 50, 1741-1748.
33. Saldeen, J., and Welsh, N. (1994) Interleukin-1 beta induced activation of NF-kappa B in insulin producing RINm5F cells is prevented by the protease inhibitor N alpha-p-tosyl-L-lysine chloromethylketone. Biochem. Biophys. Res. Commun. 203, 149-155.
34. Heimberg, H., Heremans, Y., Jobin, C., Leemans, R., Cardozo, A. K., Darville, M., and Eizirik, D. L. (2001) Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes 50, 2219-2224.
35. Urusova, I. A., Farilla, L., Hui, H., D'Amico, E., and Perfetti, R. (2004) GLP-1 inhibition of pancreatic islet cell apoptosis. Trends Endocrinol. Metab 15, 27-33.
36. Giannoukakis, N., Rudert, W. A., Ghivizzani, S. C., Gambotto, A., Ricordi, C., Trucco, M., and Robbins, P. D. (1999) Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. Diabetes 48, 1730-1736.
37. Yang, Z., Chen, M., Wu, R., Fialkow, L. B., Bromberg, J. S., McDuffie, M., Naji, A., and Nadler, J. L. (2002) Suppression of autoimmune diabetes by viral IL-10 gene transfer. J. Immunol. 168, 6479-6485.
38. Park, M. K., Kim, D. K., and Lee, H. J. (2003) Adenoviral mediated hepatocyte growth factor gene attenuates hyperglycemia and beta cell destruction in overt diabetic mice, Exp. Mol Med. 35, 494-500.
39. Lopez-Talavera, J. C., Garcia-Ocana, A., Sipula, I., Takane, K. K., Cozar-Castellano, I., and Stewart, A. F. (2004) Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. Endocrinology 145, 467-474.
40. Lakey, J. R., Pardue, D., Calvin, S., Albertson, T. E., Cavanagh, T. J., and Jacobsen. L. (1998) Nonviral transfection of isolated islets of Langerhans. Transplant. Proc. 30, 469.
41. Ju, Q., Edelstein, D., Brendel, M. D., Brandhorst, D., Brandhorst, H., Bretzel, R. G., and Brownlee, M. (1998) Transduction of non-dividing adult human pancreatic beta cells by an integrating lentiviral vector. Diabetologia 41, 736-739.
42. Leibowitz, G., Beattie, G. M., Kafri, T., Cirulli, V., Lopez, A. D., Hayek, A., and Levine, F. (1999) Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 48, 745-753.
43. Guo, Z., Shen, J., Mital, D., Hong, Y., Jensik, S. C., Alemany, R., Zhong, W. W., and Williams, J. W. (1999) Comparison of viral genedeleted adenoviral vectors with the E1-deleted adenoviral vector in islets. Transplant. Proc. 31, 794.
44. Flotte, T., Agarwal, A., Wang, J., Song, S., Fenjves, E. S., Inverardi, L., Chesnut, K., Afione, S., Loiler, S., Wasserfall, C., et al, (2001) Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors. Diabetes 50, 515-520.
45. Curran, M. A., Ochoa, M. S., Molano, R. D., Pileggi, A., Inverardi, L., Kenyon, N. S., Nolan, G. P., Ricordi, C., and Fenjves, E. S. (2002) Efficient transduction of pancreatic islets by feline immunodeficiency virus vectorsl. Transplantation 74, 299-306.
46. Demeterco, C., and Levine, F. Gene therapy for diabetes. Front. Biosci. 2001 Feb. 1.; 6.: D175.-91. 6:D175-91., D175-D191.
47. Wadia, J. S., and Dowdy, S. F. (2002) Protein transduction technology, Curr. Opin. Biotechnol. 13, 52-56.
48. Mi, Z., Mai, J., Lu, X., and Robbins, P. D. (2000) Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol. Ther. 2, 339-347.
49. Embury, J., Klein, D., Pileggi, A., Ribeiro, M., Jayaraman, S., Molano, R. D., Fraker, C., Kenyon, N., Ricordi, C., Inverardi, L., et al. (2001) Proteins linked to a protein transduction domain efficiently transduce pancreatic islets. Diabetes 50, 1706-1713.
50. Rehman, K. K., Bertera, S., Bottino, R., Balamurugan, A. N., Mai, J. C., Mi, Z., Trucco, M., and Robbins, P. D. (2003) Protection of islets by in situ peptide-mediated transduction of the Ikappa B kinase inhibitor Nemo-binding domain peptide. J. Biol. Chem. 278, 9862-9868.
51. Riachy, R., Vandewalle, B., Kerr, C. J., Moerman, E., Sacchetti, P., Lukowiak, B., Gmyr, V., Bouckenooghe, T., Dubois, M., and Pattou, F. (2002) 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. Endocrinology 143, 4809-4819.
52. Contreras, J. L., Smyth, C. A., Bilbao, G., Young, C. J., Thompson, J. A., and Eckhoff, D. E. (2002) 17beta-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality. Transplantation 14, 1252-1259.
53. Gunther, L., Berberat, P. O., Haga, M., Brouard, S., Smith, R. N., Soares, M. P., Bach, F. H., and Tobiasch, E. (2002) Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation. Diabetes 51, 994-999.
54. Tran, P. O., Gleason, C. E., Poitout, V., and Robertson, R. P. (1999) Prostaglandin E(2) mediates inhibition of insulin secretion by interleukin-1beta. J. Biol. Chem. 274, 31245-31248.
55. Farilla, L., Bulotta, A., Hirshberg, B., Li, C. S., Khoury, N., Noushmehr, H., Bertolotto, C., Di Mario, U., Harlan, D. M., and Perfetti, R. (2003) Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144, 5149-5158.
56. Mabley, J. G., Belin, V., John, N., and Green, I. C. (1997) Insulin-like growth factor I reverses interleukin-lbeta inhibition of insulin secretion, induction of nitric oxide synthase and cytokine-mediated apoptosis in rat islets of Langerhans. FEBS Lett. 417, 235-238.
57. Chen, M., Yang, Z., Wu, R., and Nadler, J.L. (2002) Lisofylline, a novel antiinflammatory agent, protects pancreatic beta-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism. Endocrinology 143, 2341-2348.
58. Goto, M., Johansson, H., Maeda, A., Elgue, G., Korsgren, O., and Nilsson, B. (2004) Low-molecular weight dextran sulfate abrogates the instant blood-mediated inflammatory reaction induced by adult porcine islets both in vitro and in vivo. Transplant. Proc. 36, 1186-1187.
59. Pileggi, A., Molano, R. D., Berney, T., Cattan, P., Vizzardelli, C., Oliver, R., Fraker, C., Ricordi, C., Pastori, R. L., Bach, F. H., et al. (2001) Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50, 1983-1991.
60. Ozmen, L., Ekdahl, K. N., Elgue, G., Larsson, R., Korsgren, O., and Nilsson, B. (2002) Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 51, 1779-1784.
61. Eizirik, D. L., Sandier, S., Welsh, N., Bendtzen, K., and Hellerstrom, C. (1994) Nicotinamide decreases nitric oxide production and partially protects human pancreatic islets against the suppressive effects of combinations of cytokines. Autoimmunity 19, 193-198.
62. Moberg, L., Olsson, A., Berne. C., Felldin, M., Foss, A., Kallen, R., Salmela, K., Tibell, A., Tufveson, G., Nilsson, B., et al. (2003) Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation. Transplantation 76, 1285-1288.
63. Kwon, G., Xu, G., Marshall, C. A., and McDaniel, M. L. (1999) Tumor necrosis factor alpha-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-Delta12,14-prostaglandin J2 and aminoguanidine. A role for peroxisome proliferator-activated receptor gamma activation and inos expression. J. Biol. Chem, 274, 18702-18708.
64. Rastellini, C., Cicalese, L., Zeevi, A., Mattes, C., Stanko, R. T., Starzl, T. E., and Rao, A. S. (1995) Long-term culture of viable human pancreatic islets in pyruvate-rich medium. Transplant. Proc. 27, 3383-3384.
65. Lakey, J. R., Helms, L. M., Kin, T., Korbutt, G. S., Rajotte, R. V., Shapiro, A. M., and Warnock, G. L. (2001) Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia. Transplantation 72, 565-570.
66. Bottino, R., Balamurugan, A. N., Bertera, S., Pietropaolo, M., Trucco, M., and Piganelli, J. D. (2002) Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. Diabetes 51, 2561-2567.
67. Contreras, J. L., Smyth, C. A., Bilbao, G., Young, C. J., Thompson, J. A., and Eckhoff, D. E. (2002) Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets. Transplantation 14, 1063-1069.
68. Arita, S., Nagai, T., Ochiai, M., Sakamoto, Y., Shevlin, L. A., Smith, C. V., and Mullen, Y. (2002) Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin. Transplantation 73, 7-12.
69. Linetsky, E., Bottino, R., Lehmann, R., Alejandro, R., Inverardi, L., and Ricordi, C. (1997) Improved human islet isolation using a new enzyme blend, liberase. Diabetes 46, 1120-1123.
70. Nakano, M., Yasunami, Y., Maki, T., Kodama, S., Ikehara, Y., Nakamura, T., Tanaka, M., and Ikeda, S. (2000) Hepatocyte growth factor is essential for amelioration of hyperglycemia in streptozotocin-induced diabetic mice receiving a marginal mass of intrahepatic islet grafts. Transplantation 69, 214-221.